Differences between Japan and rest of world (ROW) in disease presentation and outcome of previously treated adult T-cell leukemia-lymphoma (ATL) using therapy with a monoclonal antibody to CCR4, mogamulizumab (moga) Meeting Abstract


Authors: Phillips, A. A.; Horwitz, S. M.; Taylor, G. P.; Humphrey, J. S.; Tobinai, K.; Ishida, T.; Ueda, R.
Abstract Title: Differences between Japan and rest of world (ROW) in disease presentation and outcome of previously treated adult T-cell leukemia-lymphoma (ATL) using therapy with a monoclonal antibody to CCR4, mogamulizumab (moga)
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Language: English
ACCESSION: WOS:000404711505137
DOI: 10.1200/JCO.2016.34.15_suppl.e19056
PROVIDER: wos
Notes: Meeting Abstract: e19056 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz